Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Shield Thera (STX)

Price 2.75p on 03-12-2024 at 09:28:29
Change -0.10p -3.51%
Buy 2.80p
Sell 2.70p
Buy / Sell STX Shares
Last Trade: Sell 6,000.00 at 2.70p
Day's Volume: 158,693
Last Close: 2.85p
Open: 2.75p
ISIN: GB00BYV81293
Day's Range 2.75p - 2.75p
52wk Range: 1.075p - 7.65p
Market Capitalisation: £22m
VWAP: 2.713234p
Shares in Issue: 782m

Recent Trades History Shield Thera (STX)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 6,000 2.70p Ordinary
09:28:28 - 03-Dec-24
Buy* 9,029 2.76875p Ordinary
09:11:27 - 03-Dec-24
Sell* 10,000 2.70p Ordinary
08:34:34 - 03-Dec-24
Sell* 30,000 2.70p Ordinary
08:33:51 - 03-Dec-24
Sell* 97,395 2.715p Ordinary
08:30:56 - 03-Dec-24
Sell* 5,952 2.70p SI Trade
08:11:29 - 03-Dec-24
Sell* 133 2.70p SI Trade
08:11:29 - 03-Dec-24
Buy* 184 2.80p SI Trade
08:11:29 - 03-Dec-24

Share Price History for Shield Thera

Time period:
to
Date Open High Low Close Volume

Share News for Shield Thera

Shield Therapeutics shares up on strong October sales

21st Nov 2024 14:22

(Alliance News) - Shield Therapeutics PLC on Thursday said it remains on track to meet its full-year revenue covenant target following strong sales of its iron deficiency treatment. Read More

Shield Therapeutics shares slide as it expands financing arrangement

29th Oct 2024 14:34

(Alliance News) - Shield Therapeutics PLC on Tuesday said it has strengthened its financial foundation in the hope of becoming cash flow positive by the end of 2025. Read More

LONDON MARKET MIDDAY: FTSE 100 remains red ahead of US data

4th Sep 2024 12:08

(Alliance News) - Stock prices in London were lower at midday on Wednesday, despite positive service sector data, as the market continued to process a sour September start for stocks across the pond. Read More

Shield Therapeutics revenue triples, but cost rises widen annual loss

4th Sep 2024 11:39

(Alliance News) - Shield Therapeutics PLC said on Wednesday that its revenue had multiplied threefold, but an increased cost of sales after its US expansion had still widened annual loss. Read More

AIM WINNERS & LOSERS: Rockfire Resources hails Molaoi resource upgrade

4th Sep 2024 11:06

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday. Read More

FTSE 100 Latest
Value8,366.69
Change53.80

Login to your account

Forgot Password?

Not Registered